After closing at $0.95 in the most recent trading day, OrganiGram Holdings Inc. (NASDAQ: OGI) closed at 0.90, down -4.98%. In other words, the price has decreased by $-0.0472 from its previous closing price. On the day, 1096771 shares were traded. OGI reached its highest trading level at $0.9500 during the session, while it also had its lowest trading level at $0.9000.
Our goal is to gain a better understanding of OGI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.10 and its Current Ratio is at 4.20. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.04 while its Price-to-Book (P/B) ratio in mrq is 0.55.
Stock Price History:
Over the past 52 weeks, OGI has reached a high of $2.55, while it has fallen to a 52-week low of $0.90. The 50-Day Moving Average of the stock is 1.0693, while the 200-Day Moving Average is calculated to be 1.3520.
The stock has traded on average 1.82M shares per day over the past 3-months and 1.03M shares per day over the last 10 days, according to various share statistics. A total of 311.06M shares are outstanding, with a floating share count of 255.17M. Insiders hold about 18.66% of the company’s shares, while institutions hold 13.93% stake in the company. Shares short for OGI as of Jul 14, 2022 were 10.03M with a Short Ratio of 4.76, compared to 13.21M on Jun 14, 2022.
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of $-0.02 for the current quarter, with a high estimate of $-0.02 and a low estimate of $-0.02, while EPS last year was $-0.07. The consensus estimate for the next quarter is $-0.02, with high estimates of $-0.02 and low estimates of $-0.02.
Analysts are recommending an EPS of between $-0.04 and $-0.04 for the fiscal current year, implying an average EPS of $-0.04. EPS for the following year is $-0.05, with 1 analysts recommending between $-0.05 and $-0.05.
1 analysts predict $34.48M in revenue for the current quarter. It ranges from a high estimate of $34.48M to a low estimate of $34.48M. As of the current estimate, OrganiGram Holdings Inc.’s year-ago sales were $19.87M, an estimated increase of 73.50% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $29.33M, an increase of 23.10% less than the figure of $73.50% in the same quarter last year. There is a high estimate of $29.33M for the next quarter, whereas the lowest estimate is $29.33M.
A total of 1 analysts have provided revenue estimates for OGI’s current fiscal year. The highest revenue estimate was $112.81M, while the lowest revenue estimate was $112.81M, resulting in an average revenue estimate of $112.81M. In the same quarter a year ago, actual revenue was $63.27M, up 78.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $158.99M in the next fiscal year. The high estimate is $158.99M and the low estimate is $158.99M. The average revenue growth estimate for next year is up 40.90% from the average revenue estimate for this year.